These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8490473)

  • 1. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
    Booy R; Hodgson S; Griffiths H; Chapel HM; Moxon ER
    BMJ; 1993 Apr; 306(6883):971-2. PubMed ID: 8490473
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
    Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
    Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
    [No Abstract]   [Full Text] [Related]  

  • 3. [When should vaccination against Haemophilus influenzae type b take place?].
    Stickl HA
    Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
    Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
    Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against Haemophilus influenzae].
    Huber EG
    Padiatr Padol; 1991; 26(4):203-4. PubMed ID: 1749631
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
    Claesson BA; Schneerson R; Trollfors B; Lagergård T; Taranger J; Robbins JB
    J Pediatr; 1990 Jun; 116(6):929-31. PubMed ID: 2348298
    [No Abstract]   [Full Text] [Related]  

  • 7. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
    Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
    Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
    J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
    Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
    N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents.
    Kristensen K
    Scand J Infect Dis; 1992; 24(5):629-32. PubMed ID: 1465581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae B immunisation.
    Drug Ther Bull; 1993 Jan; 31(1):1-2. PubMed ID: 8440158
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Claesson BA; Trollfors B; Anderson PW; Johansson J; Taranger J; Schneerson R; Robbins JB
    Pediatr Infect Dis J; 1996 Feb; 15(2):170-2. PubMed ID: 8822293
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.
    Booy R; Taylor SA; Dobson SR; Isaacs D; Sleight G; Aitken S; Griffiths H; Chapel H; Mayon-White RT; Macfarlane JA
    Arch Dis Child; 1992 Apr; 67(4):475-8. PubMed ID: 1580674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine.
    Rowe JE; Messinger IK; Schwendeman CA; Popejoy LA
    Mil Med; 1990 Oct; 155(10):483-6. PubMed ID: 2122290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
    Weinberg GA; Granoff DM
    Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.